Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: Evidence from a case-control study

American Journal of Gastroenterology

Volumn 102, Issue 6, 2007, Pages 1251-1258

  Valenti, Luca ^a,d   Fracanzani, Anna Ludovica ^a   Dongiovanni, Paola ^a   Bugianesi, Elisabetta ^b   Marchesini, Giulio ^c   Manzini, Paola ^d   Vanni, Ester ^b   Fargion, Silvia ^a,e  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d MOLINETTE HOSPITAL   (Italy)

^e FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; FERRITIN;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CONTROLLED STUDY; DIET; FEMALE; GENE MUTATION; HEMOCHROMATOSIS; HUMAN; HYPERFERRITINEMIA; INSULIN RESISTANCE; IRON DEPLETION; IRON STORAGE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; PATIENT COUNSELING; PHLEBOTOMY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SEX DIFFERENCE; TREATMENT OUTCOME;

BLOOD GLUCOSE; BODY WEIGHT; CASE-CONTROL STUDIES; FATTY LIVER; FEMALE; FERRITINS; HEMOCHROMATOSIS; HUMANS; INSULIN RESISTANCE; IRON; LIVER; MALE; MIDDLE AGED; PHLEBOTOMY;

EID: 34249098685     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01192.x     Document Type: Article

References (44)

1. Browning JD, Szczepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. Hepatology 2004 40 : 1387 95.
2. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003 37 : 917 23.
3. Villanova N, Moscatiello S, Ramilli S, et al. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 2005 42 : 473 80.
4. Targher G, Bertolini L, Padovani R, et al. Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: Role of visceral fat accumulation. Diabetes Care 2004 27 : 2498 500.
5. Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 1999 107 : 450 5.
6. Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes 2001 50 : 1844 50.
7. Suzuki A, Angulo P, Lymp J, et al. Chronological development of elevated aminotransferases in a nonalcoholic population. Hepatology 2005 41 : 64 71.
8. Suzuki A, Lindor K, St. Saver J, et al. Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease. J Hepatol 2005 43 : 1060 6.
9. Bugianesi E, Marzocchi R, Villanova N, et al. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): Treatment. Best Pract Res Clin Gastroenterol 2004 18 : 1105 16.
10. Promrat K, Lutchman G, Uwaifo GI, et al. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology 2004 39 : 188 96.
11. Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, et al. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone. Hepatology 2003 38 : 1008 17.
12. Bugianesi E, Gentilcore E, Manini R, et al. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am J Gastroenterol 2005 100 : 1082 90.
13. Valenti L, Dongiovanni P, Fracanzani AL, et al. Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis. Dig Liver Dis 2003 35 : 172 8.
14. Bugianesi E, Manzini P, D'Antico S, et al. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatology 2004 39 : 179 87.
15. Moirand R, Mendler MH, Guillygomarc'h A, et al. Non-alcoholic steatohepatitis with iron: Part of insulin resistance-associated hepatic iron overload? J Hepatol 2000 33 : 1024 6.
16. Mendler MH, Turlin B, Moirand R, et al. Insulin resistance-associated hepatic iron overload. Gastroenterology 1999 117 : 1155 63.
17. Turlin B, Mendler MH, Moirand R, et al. Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients. Am J Clin Pathol 2001 116 : 263 70.
18. Valenti L, Dongiovanni P, Piperno A, et al. Alpha1-antitrypsin mutations in NAFLD: High prevalence and association with altered iron metabolism but not with liver damage. Hepatology 2006 44 : 857 64.
19. Zacharski LR, Chow BK, Howes PS, et al. Implementation of an iron reduction protocol in patients with peripheral vascular disease: VA cooperative study no. 410: The Iron (Fe) and Atherosclerosis Study (FeAST). Am Heart J 2004 148 : 386 92.
20. Bozzini C, Girelli D, Olivieri O, et al. Prevalence of body iron excess in the metabolic syndrome. Diabetes Care 2005 28 : 2061 3.
21. Jehn M, Clark JM, Guallar E. Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care 2004 27 : 2422 8.
22. Wrede CE, Buettner R, Bollheimer LC, et al. Association between serum ferritin and the insulin resistance syndrome in a representative population. Eur J Endocrinol 2006 154 : 333 40.
23. Shi Z, Hu X, Yuan B, et al. Association between serum ferritin, hemoglobin, iron intake, and diabetes in adults in Jiangsu, China. Diabetes Care 2006 29 : 1878 83.
24. Fernandez-Real JM, Lopez-Bermejo A, Ricart W. Cross-talk between iron metabolism and diabetes. Diabetes 2002 51 : 2348 54.
25. Fargion S, Dongiovanni P, Guzzo A, et al. Iron and insulin resistance. Aliment Pharmacol Ther 2005 22 (Suppl 2 61 3.
26. Niederau C, Berger M, Stremmel W, et al. Hyperinsulinaemia in non-cirrhotic haemochromatosis: Impaired hepatic insulin degradation? Diabetologia 1984 26 : 441 4.
27. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006 440 : 944 8.
28. Guillygomarc'h A, Mendler MH, Moirand R, et al. Venesection therapy of insulin resistance-associated hepatic iron overload. J Hepatol 2001 35 : 344 9.
29. Facchini FS, Hua NW, Stoohs RA. Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease. Gastroenterology 2002 122 : 931 9.
30. Valenti L, Fracanzani AL, Fargion S. Effect of iron depletion in patients with nonalcoholic fatty liver disease without carbohydrate intolerance. Gastroenterology 2003 124 : 866 author reply 80-7.
31. Fernandez-Real JM, Penarroja G, Castro A, et al. Blood letting in high-ferritin type 2 diabetes: Effects on insulin sensitivity and beta-cell function. Diabetes 2002 51 : 1000 4.
32. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000 23 : 57 63.
33. Fargion S, Mattioli M, Fracanzani AL, et al. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am J Gastroenterol 2001 96 : 2448 55.
34. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002 106 : 3143 421.
35. Facchini FS, Saylor KL. Effect of iron depletion on cardiovascular risk factors: Studies in carbohydrate-intolerant patients. Ann N Y Acad Sci 2002 967 : 342 51.
36. Piperno A, Vergani A, Salvioni A, et al. Effects of venesections and restricted diet in patients with the insulin-resistance hepatic iron overload syndrome. Liver Int 2004 24 : 471 6.
37. Sumida Y, Kanemasa K, Fukumoto K, et al. Effect of iron reduction by phlebotomy in Japanese patients with nonalcoholic steatohepatitis: A pilot study. Hepatol Res 2006 33 : 135
38. Marchesini G, Suppini A, Forlani G. NAFLD treatment: Cognitive-behavioral therapy has entered the arena. J Hepatol 2005 43 : 926 8.
39. Green A, Basile R, Rumberger JM. Transferrin and iron induce insulin resistance of glucose transport in adipocytes. Metabolism 2006 55 : 1042 5.
40. Fernandez-Real JM, Lopez-Bermejo A, Ricart W. Iron stores, blood donation, and insulin sensitivity and secretion. Clin Chem 2005 51 : 1201 5.
41. Facchini FS. Effect of phlebotomy on plasma glucose and insulin concentrations. Diabetes Care 1998 21 : 2190.
42. Bugianesi E, Leone N, Vanni E, et al. Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002 123 : 134 40.
43. Fernandez-Real JM, Penarroja G, Castro A, et al. Blood letting in high-ferritin type 2 diabetes: Effects on vascular reactivity. Diabetes Care 2002 25 : 2249 55.
44. McClain DA, Abraham D, Rogers J, et al. High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis. Diabetologia 2006 49 : 1661 9.